Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  CANADIAN NATIONAL STOCK EXCHANGE  >  Better Plant Sciences Inc.    PLNT   CA0877371025

BETTER PLANT SCIENCES INC.

(PLNT)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensus 
SummaryAll NewsPress ReleasesOfficial PublicationsSector news

Better Plant Sciences Submits Application for Ayurvedic Skin Ointment to Combat Infectious Disease

share with twitter share with LinkedIn share with facebook
08/25/2020 | 06:05am EDT

Vancouver, British Columbia--(Newsfile Corp. - August 25, 2020) - Better Plant Sciences Inc. (CSE: PLNT) (OTCQB: BOSQF) (FSE:YG3) ("Better") subsidiary Urban Juve Provisions Inc. ("Urban Juve") announces that it has conducted research and development into plant-based topical products that fight against or prevent infectious diseases leading to the submission of a Natural Health Product ("NHP") application for a plant-based, antiseptic skin ointment to Health Canada to obtain an NHP number for the product.

Cannot view this image? Visit: https://orders.newsfilecorp.com/files/6377/62448_betterplantsciences.jpg


Better Plant Sciences Submits Application for Ayurvedic Skin Ointment to Combat Infectious Disease

To view an enhanced version of this graphic, please visit:
https://orders.newsfilecorp.com/files/6377/62448_PR_WEB_BetterPlantSciences.jpg

"This plant-based skin ointment was developed using the principles of Ayurveda. We have spent the last six months working to identify the plants with the most active compounds with antibacterial and antiviral properties," says Bhavna Solecki, Director of Research and Product Development at Better Plant Sciences. "We are very pleased with the resulting plant-based antiseptic skin repair and healing ointment formula we have developed to be used to help heal minor skin wounds, cuts, burns, and bruises."

According to the Natural Health Products Regulations, compendial product licence applications such as this are processed within 60-days of receipt.

GM Insights reported that the global wound care biologics market was worth US$ 1.40 Billion in 2018 and is expected to reach a value of US$ 2.5 Billion by 2025 with a CAGR of around 9%. Wound care biologics refer to drugs extracted or semi-synthesized from natural sources which are used for controlling and healing infections.

The Better Plant Sciences research and development team focused on using polyherbal combinations, which use a group of plants to achieve an effective therapeutic effect. In Ayurveda, most classical preparations are polyherbal, involving a combination of 3 to 30 plants that are combined in precise ratios to achieve the desired result.

"During the compounding process, one or two of the plants will be active and the others play a supporting role. The supporting herbs have different therapeutic values calculated for different purposes, which act as catalysts to help proper absorption, transportation, and to reduce toxicity," added Solecki. "We use spices because the phytochemicals within spices are secondary metabolites, which serve to protect against damage by insects, animals, fungi, pathogens, and parasites."

About Better Plant Sciences Inc.

Better develops and acquires intellectual property and other assets related to plant-based products and therapeutics, and develops, manufactures, markets, sells and distributes plant-based products that improve lives. It has 14 patent applications to protect its formulas and over 200 proprietary wellness formulas at various stages of commercialization, including over 20 products that are now for sale via e-commerce or brick and mortar retail stores. It has signed an agreement to acquire JUSU branded plant-based assets from JUSU Bar, JUSU Body and JUSU Cbd, and expects to complete the acquisition this fall. The acquisition includes all inventory, packaging, raw ingredients, and intellectual property related to 300 plant-based products as well as the e-commerce sites where those products are sold. Its majority-owned subsidiary NeonMind Biosciences Inc. is engaged in research into developing a psilocybin (psychedelic mushroom) based product for weight loss and is developing a line of coffees infused with health optimizing medicinal mushrooms including reishi, cordyceps, lion's mane and turkey tail mushrooms.

Investor Relations Contact:

Kevan Matheson, Investor Relations
invest@betterplantsciences.com
1-833-514-2677

The Canadian Securities Exchange has not reviewed, approved or disapproved the contents of this news release.

Cautionary Statement Regarding Forward-Looking Statements

This press release includes forward-looking information and statements (collectively, "forward looking statements") under applicable Canadian securities legislation. Forward-looking statements are necessarily based upon a number of estimates, forecasts, beliefs and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such risks, uncertainties and factors include, but are not limited to: risks related to the development, testing, licensing, brand development, availability of packaging, intellectual property protection, reduced global commerce and reduced access to raw materials and other supplies due to the spread of the Coronavirus, the potential for not acquiring any rights as a result of the patent application and any products making use of the intellectual property may be ineffective or the company may be unsuccessful in commercializing them; and other approvals will be required before commercial exploitation of the intellectual property can happen. Demand for the company's products, general business, economic, competitive, political and social uncertainties, delay or failure to receive board or regulatory approvals where applicable, and the state of the capital markets. Better cautions readers not to place undue reliance on forward-looking statements provided by Better, as such forward-looking statements are not a guarantee of future results or performance and actual results may differ materially. The forward-looking statements contained in this press release are made as of the date of this press release, and Better expressly disclaims any obligation to update or alter statements containing any forward-looking information, or the factors or assumptions underlying them, whether as a result of new information, future events or otherwise, except as required by law.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/62448


© Newsfilecorp 2020
share with twitter share with LinkedIn share with facebook
All news about BETTER PLANT SCIENCES INC.
09/17Better Plant Sciences Announces Wright & Well Packaging Acclaimed by Leading ..
NE
09/16HEALTHY INVESTING : Why It's Time to Jump into the Plant-Based Revolution
NE
09/15Better Plant Sciences Announces JUSU Juices Now Available for Home Delivery i..
NE
09/10Better Plant Sciences Ready for US Sales of its FDA Listed Gel-Based Hand San..
NE
09/09The Plant-Based Market is Creating an Incredible $20.8 Billion Opportunity
NE
09/03Better Plant Sciences Announces OTC Ticker Symbol Change to "VEGGF"
NE
09/01Better Plant Sciences Adds eCommerce Sales of 200 Plant-Based Products Throug..
NE
08/27Better Plant Sciences Announces Website Launch and Strategic Plan to Grow Dir..
NE
08/25Better Plant Sciences Submits Application for Ayurvedic Skin Ointment to Comb..
NE
08/20NeonMind Ready to Launch Four Mushroom Coffee Blends
NE
More news
Financials
Sales 2019 4,02 M 3,04 M 3,04 M
Net income 2019 -16,0 M -12,1 M -12,1 M
Net cash 2019 0,54 M 0,41 M 0,41 M
P/E ratio 2019 -1,43x
Yield 2019 -
Capitalization 12,0 M 9,10 M 9,08 M
EV / Sales 2018 -
EV / Sales 2019 6,43x
Nbr of Employees 19
Free-Float 71,1%
Chart BETTER PLANT SCIENCES INC.
Duration : Period :
Better Plant Sciences Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BETTER PLANT SCIENCES INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 1
Average target price 0,45 CAD
Last Close Price 0,08 CAD
Spread / Highest target 463%
Spread / Average Target 463%
Spread / Lowest Target 463%
Managers
NameTitle
Penny White President, Chief Executive Officer & Director
Tamara Melck Chief Operating Officer
Yu Cai Huang Chief Financial Officer
Spiros Margaris Independent Director
Cole Drezdoff Director
Sector and Competitors
1st jan.Capitalization (M$)
BETTER PLANT SCIENCES INC.-60.53%9
JOHNSON & JOHNSON2.27%392 765
ROCHE HOLDING AG9.27%322 209
MERCK & CO., INC.-5.65%217 034
PFIZER, INC.-6.02%203 549
NOVARTIS AG-9.76%200 978